Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 307

ApoGen applies itself to $7m series A

Washington Research Foundation and Arch Venture Partners are among the investors in the genomic cancer treatment spinout of University of Minnesota.

Dec 14, 2016

ApoGen applies itself to $7m series A

AbbVie, Eli Lilly, WuXi PharmaTech, Johnson & Johnson and Alexandria Real Estate Equities are among the investors in the genomic cancer treatment developer.

Dec 14, 2016

Mojio revs up series A to $15m

Amazon provided a $7m extension to the connected car technology developer's series A round, which already contained Deutsche Telekom.

Dec 13, 2016

BlueRock Therapeutics generates $225m series A

Bayer Lifescience Center joined Versant Ventures to launch BlueRock, a Kyoto spinout that will develop stem cell treatments for cardiovascular diseases and neurodegenerative disorders.

Dec 13, 2016

BlueRock Therapeutics generates $225m series A

Bayer Lifescience Center joined Versant Ventures to launch BlueRock, which will develop stem cell treatments for cardiovascular diseases and neurodegenerative disorders.

Dec 13, 2016

Vesper sounds out corporates for $15m series A

Michigan spinout Vesper's investors include Amazon's Alexa Fund, AAC Technologies, Mirae Nano Tech and XinGang Electronics.

Dec 12, 2016

Vesper sounds out corporates for $15m series A

Advanced microphone technology developer Vesper's investors include Amazon's Alexa Fund, AAC Technologies, Mirae Nano Tech and XinGang Electronics.

Dec 12, 2016

Eutilex utilises Kooksoondang in series A round

Kooksoondang Brewery's GN Tech Venture was among the investors in an $18.9m round that took the anti-tumour therapy developer's total funding to $27.7m.

Dec 12, 2016
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here